Date：27 July (Wednesday) 09:00 – 12:10 (GMT+8)
Venue：701EF, TaiNEX2, Taipei + Online event platform
The biomedical industry has emerged from the pandemic era with a new emphasis on speed; processes put in place to accelerate COVID-19 drug and vaccine development have become entrenched, and there’s no turning back. The promise of AI and technology-driven innovation pre-pandemic has fast become reality, while digital transformation accelerates across every segment of the life sciences value chain. Additionally, remote communication and new working models born out of necessity during pandemic lockdown are today fueling new levels of interaction and engagement, within and across borders and even across disciplines, and with it, the promise of a wellspring of new innovation. The future looks bright; with the Asian biomedical ecosystem and its myriad stakeholders well placed to benefit from this new global paradigm of speed and seamless engagement. Join us in this Plenary Session as our esteemed panel of international experts examines these opportunities and more, with discussion under four broad themes of the conference: markets and ecosystems, policy and regulation, technology and solutions, and investment and collaborations.